Tumor γδ T-cell abundance is associated with favorable cancer treatment outcomes
Purpose Clinical response to immune checkpoint blockade (ICB) remains variable. We performed a reference-wide screen to identify immune-cell populations in the tumor microenvironment (TME) associated with benefit across treatment modalities and tumor types. Experimental Design We analyzed pretreatment bulk tumor RNA-se...